Old Web
English
Sign In
Acemap
>
authorDetail
>
Maria E. Chopivsky
Maria E. Chopivsky
University of Virginia Health System
KRAS
Pancreatic cancer
Lapatinib
Cancer research
MAPK/ERK pathway
2
Papers
68
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib
2013
Neoplasia
Dustin M. Walters
James M. Lindberg
Sara J. Adair
Timothy E. Newhook
Catharine R. Cowan
Jayme B. Stokes
Cheryl A. Borgman
Edward B. Stelow
Bryce T. Lowrey
Maria E. Chopivsky
Tona M. Gilmer
J.T. Parsons
Todd W. Bauer
Show All
Source
Cite
Save
Citations (68)
Acquired resistance to combination therapy with lapatinib and MEK 1/2 inhibitor GSK1120212 in an in vivo murine model of pancreatic cancer.
2012
Journal of Clinical Oncology
James M. Lindberg
Dustin M. Walters
Sara J. Adair
Catharine R. Cowan
Jayme B. Stokes
Cheryl A. Borgman
Edward B. Stelow
Bryce Lowrey
Maria E. Chopivsky
J. Thomas Parsons
Todd W. Bauer
Show All
Source
Cite
Save
Citations (0)
1